There are a number of models that look at innovating payments and focus on care delivery changes in oncology that are a positive step forward for patients, Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology, said at the Community Oncology Alliance's 2016 Community Oncology Conference.
There are a number of models that look at innovating payments and focus on care delivery changes in oncology that are a positive step forward for patients, Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology, said at the Community Oncology Alliance's 2016 Community Oncology Conference.
Transcript (slightly modified)
What changes would you like to see with the way cancer care is paid for and delivered?
Cancer care is going through a time of great change. I would love to see changes in the care delivery system and how the care delivery system is reimbursed moving forward. I think it's in the best interest of patients to do that. I'm very excited by the Oncology Care Model, as I think there are many quality metrics that are really important that are emphasized in that model. And incorporation of evidence-based platforms of prescribing, like in Texas Oncology, where I work and see patients, we use value pathways in collaboration with the US Oncology Network. So I think facilitating evidence-based behavior and facilitating quality is going to be important in payment models moving forward.
I think the Oncology Care Model isn't the only model though it's a good one—or at least preliminarily it looks like a good one with regards to the systems changes that we need in oncology. We want to be able to be responsible for our patients to make changes in our staffing to make sure we get acute care patients in right away so they're not sent to the hospital system, so we can decrease emergency room visits and hospitalizations.
But the Oncology Care Model is not the only way to do that. There are other pilots that have been positive, looking at total system changes of care delivery. Texas Oncology has had a pilot with Aetna, we have a pilot today with UnitedHealth, there is the Patient-Centered Medical Home model, which COA has been a great part of. ASCO has the PCOP [Patient-Centered Oncology Payment] model.
So there are many other models moving foward that look at innovating payments that really focus around care delivery changes that I think is a positive movement forward and I think in the best interests of patients.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More